214 related articles for article (PubMed ID: 19176390)
1. A gonadotropin-releasing hormone-II antagonist induces autophagy of prostate cancer cells.
Kim DK; Yang JS; Maiti K; Hwang JI; Kim K; Seen D; Ahn Y; Lee C; Kang BC; Kwon HB; Cheon J; Seong JY
Cancer Res; 2009 Feb; 69(3):923-31. PubMed ID: 19176390
[TBL] [Abstract][Full Text] [Related]
2. Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation.
Meeran SM; Katiyar S; Katiyar SK
Toxicol Appl Pharmacol; 2008 May; 229(1):33-43. PubMed ID: 18275980
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic death of prostate cancer cells by a gonadotropin-releasing hormone-II antagonist.
Park S; Han JM; Cheon J; Hwang JI; Seong JY
PLoS One; 2014; 9(6):e99723. PubMed ID: 24926857
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone type II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivo.
Fister S; Günthert AR; Emons G; Gründker C
Cancer Res; 2007 Feb; 67(4):1750-6. PubMed ID: 17308117
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species.
Chen Y; McMillan-Ward E; Kong J; Israels SJ; Gibson SB
J Cell Sci; 2007 Dec; 120(Pt 23):4155-66. PubMed ID: 18032788
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype.
Kumar B; Koul S; Khandrika L; Meacham RB; Koul HK
Cancer Res; 2008 Mar; 68(6):1777-85. PubMed ID: 18339858
[TBL] [Abstract][Full Text] [Related]
7. Pancratistatin induces apoptosis and autophagy in metastatic prostate cancer cells.
Griffin C; McNulty J; Pandey S
Int J Oncol; 2011 Jun; 38(6):1549-56. PubMed ID: 21424119
[TBL] [Abstract][Full Text] [Related]
8. Chronic high-dose morphine treatment promotes SH-SY5Y cell apoptosis via c-Jun N-terminal kinase-mediated activation of mitochondria-dependent pathway.
Lin X; Wang YJ; Li Q; Hou YY; Hong MH; Cao YL; Chi ZQ; Liu JG
FEBS J; 2009 Apr; 276(7):2022-36. PubMed ID: 19292871
[TBL] [Abstract][Full Text] [Related]
9. Peptides and antitumor activity. Development and investigation of some peptides with antitumor activity.
Teplán I
Acta Biol Hung; 2000; 51(1):1-29. PubMed ID: 10866357
[TBL] [Abstract][Full Text] [Related]
10. Rapid suppression of plasma testosterone levels and tumor growth in the dunning rat model treated with degarelix, a new gonadotropin-releasing hormone antagonist.
Princivalle M; Broqua P; White R; Meyer J; Mayer G; Elliott L; Bjarnason K; Haigh R; Yea C
J Pharmacol Exp Ther; 2007 Mar; 320(3):1113-8. PubMed ID: 17179469
[TBL] [Abstract][Full Text] [Related]
11. Statin-induced autophagy by inhibition of geranylgeranyl biosynthesis in prostate cancer PC3 cells.
Parikh A; Childress C; Deitrick K; Lin Q; Rukstalis D; Yang W
Prostate; 2010 Jun; 70(9):971-81. PubMed ID: 20135644
[TBL] [Abstract][Full Text] [Related]
12. A 60-Hz sinusoidal magnetic field induces apoptosis of prostate cancer cells through reactive oxygen species.
Koh EK; Ryu BK; Jeong DY; Bang IS; Nam MH; Chae KS
Int J Radiat Biol; 2008 Nov; 84(11):945-55. PubMed ID: 19016143
[TBL] [Abstract][Full Text] [Related]
13. Gonadotropin releasing hormone analogs induce apoptosis by extrinsic pathway involving p53 phosphorylation in primary cell cultures of human prostatic adenocarcinomas.
Clementi M; Sánchez C; Benitez DA; Contreras HR; Huidobro C; Cabezas J; Acevedo C; Castellón EA
Prostate; 2009 Jul; 69(10):1025-33. PubMed ID: 19301301
[TBL] [Abstract][Full Text] [Related]
14. Differential involvement of reactive oxygen species and nucleoside transporters in cytotoxicity induced by two adenosine analogues in human prostate cancer cells.
Minelli A; Bellezza I; Tucci A; Rambotti MG; Conte C; Culig Z
Prostate; 2009 Apr; 69(5):538-47. PubMed ID: 19107848
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alpha.
Wu HM; Cheng JC; Wang HS; Huang HY; MacCalman CD; Leung PC
Cancer Res; 2009 May; 69(10):4202-8. PubMed ID: 19366794
[TBL] [Abstract][Full Text] [Related]
16. A water-soluble parthenolide analogue suppresses in vivo prostate cancer growth by targeting NFkappaB and generating reactive oxygen species.
Shanmugam R; Kusumanchi P; Cheng L; Crooks P; Neelakantan S; Matthews W; Nakshatri H; Sweeney CJ
Prostate; 2010 Jul; 70(10):1074-86. PubMed ID: 20209491
[TBL] [Abstract][Full Text] [Related]
17. Glibenclamide exerts an antitumor activity through reactive oxygen species-c-jun NH2-terminal kinase pathway in human gastric cancer cell line MGC-803.
Qian X; Li J; Ding J; Wang Z; Duan L; Hu G
Biochem Pharmacol; 2008 Dec; 76(12):1705-15. PubMed ID: 18840412
[TBL] [Abstract][Full Text] [Related]
18. The role of serotonin (5-hydroxytryptamine1A and 1B) receptors in prostate cancer cell proliferation.
Siddiqui EJ; Shabbir M; Mikhailidis DP; Thompson CS; Mumtaz FH
J Urol; 2006 Oct; 176(4 Pt 1):1648-53. PubMed ID: 16952708
[TBL] [Abstract][Full Text] [Related]
19. Autophagy inhibits reactive oxygen species-mediated apoptosis via activating p38-nuclear factor-kappa B survival pathways in oridonin-treated murine fibrosarcoma L929 cells.
Cheng Y; Qiu F; Ye YC; Guo ZM; Tashiro S; Onodera S; Ikejima T
FEBS J; 2009 Mar; 276(5):1291-306. PubMed ID: 19187231
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.
Heinrich E; Schally AV; Buchholz S; Rick FG; Halmos G; Mile M; Groot K; Hohla F; Zarandi M; Varga JL
Prostate; 2008 Dec; 68(16):1763-72. PubMed ID: 18729085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
